Sove IT 6.25 Tablet ER
Marketer
Ipca Laboratories Ltd
Salt Composition
Zolpidem (6.25mg)
Overview Sove IT 6.25 Tablet ER
Insomnus 6.25mg Extended-Release tablets provide short-term insomnia relief. They shorten sleep onset and reduce nighttime awakenings, promoting consolidated sleep. Take Insomnus 6.25mg ER on an empty stomach, ideally just before bedtime, consistently at the same time daily for optimal blood levels. Follow your doctor's prescribed dosage and duration; this medication can be habit-forming and should not be discontinued abruptly without medical consultation, as this may exacerbate symptoms. Potential side effects, which are usually transient, include: memory impairment, visual disturbances (including double vision), dizziness, nausea, vomiting, headache, vertigo, diarrhea, back pain, agitation, fatigue, stomach discomfort, depression, and hallucinations. Report persistent or bothersome side effects to your physician. Due to drowsiness and dizziness, avoid driving or tasks requiring alertness until the medication's effects are known. Alcohol should be avoided. Report any unusual mood changes, new or worsening depression, hallucinations, or suicidal ideation to your doctor immediately. Disclose all other medications to your physician before starting Insomnus 6.25mg ER to ensure its suitability. Those with liver or kidney disease should consult their doctor before use. Smoking and alcohol should be avoided during treatment. This medication is contraindicated in pregnancy and breastfeeding; consult your physician if use is deemed necessary.
Primary Ingredients of Sove IT 6.25 Tablet ER
No text was provided to rewrite.
Uses of Sove IT 6.25 Tablet ER
Managing Sleep Difficulties
Major Benefits of Sove IT 6.25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or divide it. Administer Sove IT 6.25 Tablet ER on an empty stomach.
Common Side effects of Sove IT 6.25 Tablet ER:
- Dizziness
- Sleepiness
- Headache
- Nausea
- Stomach pain
- Memory loss
- Vertigo
- Vomiting
- Back pain
- Agitation
- Double vision
- Depression
How to use Sove IT 6.25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or break it. Administer Sove IT 6.25 Tablet ER on an empty stomach.
How Sove IT 6.25 Tablet ER works:
Sove IT 6.25 Extended-Release Tablets are classified as non-benzodiazepine sleep aids. This medication exhibits hypnotic, sedative, and anticonvulsive effects, controlling seizures. Its mechanism involves interacting with the GABAA receptor chloride channel complex, a neurotransmitter receptor, to reduce neuronal activity in the brain and promote sleep onset.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Sove IT 6.25 ER tablets and alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Extended-release Sove IT 6.25 mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Extended-release Sove IT 6.25 mg tablets are considered safe for breastfeeding mothers. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Extended-release Sove IT 6.25mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
The extended-release Sove IT 6.25mg tablet is suitable for use in individuals with kidney impairment; dose modification isn't necessary. Nevertheless, disclose any kidney conditions to your physician.
LiverCAUTION
Exercise caution when prescribing Sove IT 6.25 Tablet ER to individuals with hepatic impairment. Dosage modification of Sove IT 6.25 Tablet ER might be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate Sove IT 6.25 Tablet ER therapy at a reduced starting dose; it's contraindicated in those with severe liver disease.
What if you forget to take Sove IT 6.25 Tablet ER :
Omit any missed Sove IT 6.25 Tablet ER dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sove IT 6.25 Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Imidazopyridine-based compound |
| Developing Habits | Affirmative. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | Non-benzodiazepine sleeping pills (Z-drugs) |






